Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleoside Chemistry . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced triflation-fluorination route for pharmaceutical intermediates ensuring scalable production and reduced purification costs without column chromatography.
Patent CN1184228C details a novel non-phosphorus route for 5'-deoxy-5-fluorouridine, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN115785181A reveals a green one-pot route for Mopiravir intermediates. Achieve high purity and yield with reduced costs for reliable pharmaceutical intermediates supply.
Patent CN114573590A reveals a high-yield tetraisobutyryl nucleoside analog process. Discover cost-effective manufacturing solutions for antiviral API intermediates.
Patent CN110590886B details a novel 6'-nitrile LNA synthesis enhancing nuclease resistance. Discover scalable routes for high-affinity oligonucleotide intermediates.
Patent CN106117289B reveals stable phosphorothioate nucleosides. Enhances siRNA stability and offers scalable synthesis for high-purity pharmaceutical intermediates globally.
Novel route for Gemcitabine HCl with high yield and purity. Reduces steps and improves scalability for API manufacturing.
Patent CN101492482B details a stable TBDPS-protected route for Gemcitabine HCl, ensuring high purity (>99.8%) and industrial scalability for reliable pharmaceutical intermediate suppliers.
Patent CN113423714A details a novel sulfonylation route for 3'-O-amino-ribonucleotides, offering improved selectivity and scalability for nucleic acid manufacturing.
Novel patent CN115109104B offers mild conditions and reduced purification steps for cordycepin, ensuring supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN115703796A reveals a high-yield route for Remdesivir intermediates using methylthio-substitution, offering significant cost reduction and supply chain stability for API manufacturing.
Discover a novel mild process for Capecitabine synthesis from Furtulon. High purity, scalable route offering significant cost reduction in pharmaceutical manufacturing.
Patent CN119431334A details a high-yield synthesis of 2'OMe pseudouridine. This method offers significant cost reduction and supply chain reliability for mRNA manufacturing.
Advanced synthesis of Cangrelor intermediate via patent CN105481922B. Offers high purity, reduced toxicity, and scalable manufacturing for global pharmaceutical supply chains.